CEL-SCI to Present at the ThinkEquity Conference
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, announced today that Geert Kersten, Chief Executive…
Pharmaceuticals, Biotechnology and Life Sciences
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, announced today that Geert Kersten, Chief Executive…
BOSTON & MUNICH–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/biomarkers?src=hash" target="_blank"gt;#biomarkerslt;/agt;–Invicro LLC, a Konica Minolta company and iTheraMedical GmbH announced a unique partnership with the…
Center for Tobacco Products incorporates machine learning platform to assist toxicology research LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq:SLP), the leading…
DUBLIN–(BUSINESS WIRE)–The “Biological Safety Testing Market Size, Share & Trends Analysis Report By Product, By Application (Vaccines & Therapeutics, Gene…
First-Quarter 2019 Worldwide Sales Were $10.8 Billion, an Increase of8%; Sales Increased 11% Excluding Negative Impact from ForeignExchange; Growth Driven by Oncology and Vaccines
First-Quarter 2019 Revenues of $13.1 Billion, Reflecting 5% Operational Growth Driven by 7% Operational Growth from Pfizer Biopharmaceuticals Group and…
MONROVIA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer, autoimmune diseases,…
GRAND RAPIDS, Mich.–(BUSINESS WIRE)–Grand River Aseptic Manufacturing, Inc. (GRAM), a leading parenteral contract development and manufacturing organization, has implemented its…
BOULDER, Colo.–(BUSINESS WIRE)–Inscripta, developer of the first scalable platform for benchtop Digital Genome Engineering, today announced the appointment of Ron…
Use of Agilent’s custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics…